[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SlowBull @SlowBullHQ on x XX followers
Created: 2025-07-16 12:25:24 UTC
$JNJ Johnson & Johnson Q2 2025 Global healthcare leader in Pharmaceuticals & MedTech 🏥
Outperformed across the board: delivered mid-single-digit revenue growth and EPS above consensus; raised FY25 outlook on strong cash flow & FX tailwinds 💰📊
• Pharma: oncology led the way with robust growth & key pipeline catalysts 🚀 • MedTech: record device sales in orthopaedics & surgery 🦿 • Consumer Health: resilient demand in skincare & wellness 🧴 • Margins expanded thanks to cost discipline & efficiency gains 📈 • Returned significant capital via buybacks & dividend hike 💸 • Continued momentum in emerging markets 🌍
XX engagements
Related Topics cash flow eps quarterly earnings coins healthcare $jnj johnson johnson stocks healthcare